Mr Larry Marvin Whiting, CRNA in Cozad, NE - Nurse Anesthetist, Certified Registered

Mr Larry Marvin Whiting, CRNA is a Nurse Anesthetist, Certified Registered based in Cozad, Nebraska. Mr Larry Marvin Whiting is licensed to practice in Nebraska (license number 100118) and his current practice location is 300 East 12th Street, Cozad, Nebraska. He can be reached at his office (for appointments etc.) via phone at (308) 784-2261.

NPI number for Mr Larry Marvin Whiting is 1659462000 and his current mailing address is 609 East 14th Street, Cozad, Nebraska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1659462000.

Contact Information

	Mr Larry Marvin Whiting, CRNA
	300 East 12th Street, Cozad, NE 69130
	(308) 784-2261
	(308) 784-2266

Provider's Profile

Full Name	Mr Larry Marvin Whiting
Gender	Male
Speciality	Nurse Anesthetist, Certified Registered
Location	300 East 12th Street, Cozad, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1659462000
Provider Enumeration Date: 09/28/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Mr Larry Marvin Whiting such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659462000	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367500000X	Nurse Anesthetist, Certified Registered	100118 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Larry Marvin Whiting is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Larry Marvin Whiting, CRNA 609 East 14th Street, Cozad, NE 69130-1622 Ph: (308) 784-4261	Mr Larry Marvin Whiting, CRNA 300 East 12th Street, Cozad, NE 69130 Ph: (308) 784-2261

News Archive

Zhena's Gypsy Tea launches campaign for breast cancer awareness and prevention

Zhena's Gypsy Tea, the innovative tea company, turns up the heat on the battle against breast cancer with its campaign dedicated to urging awareness, preventing breast cancer and finding a cure. Spearheaded by the slogan; Drink Pink-Think Pink, a 70 cent donation of each sale of a the company's popular PINK SUPERBERRY TEA for Women's Health will go directly to The Breast Cancer Research Foundation(R) (BCRF), in support of finding a cure and funding clinical and genetic research worldwide.

LifeVantage pays Zrii $400,000 to settle litigation

LifeVantage Corporation, the maker of Protandim® and TrueScience(TM) Anti-Aging Cream, science-based solutions to oxidative stress, announced today that the Company has entered into a settlement agreement with, among other parties, Zrii, LLC.

Research provides better understanding of drugs used to treat, prevent cardiovascular disease

Using chemical labeling and mass spectrometry-based techniques, Mark Chance, PhD, director of the Case Western Reserve University School of Medicine Center for Proteomics and Bioinformatics and professor of physiology and biophysics; Sayan Gupta, PhD, instructor at the Case Center for Proteomics and Bioinformatics; and a research team from the University of Oxford, for the first time, were able to take a high resolution picture of the open state of a K+ channel, allowing them to comparatively analyze gating mechanisms important to heart function and nerve signaling - in addition these techniques have already permitted Case Western investigators to gain a deeper understanding of G-protein coupled receptors.

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

Treating common gum disease in CKD patients could reduce heart disease risk

Treating a common gum condition in chronic kidney disease (CKD) patients could significantly reduce their risk of potentially fatal heart disease, Aston University researchers say.

Mr Larry Marvin Whiting, CRNA - Nurse Anesthetist, Certified Registered in Cozad, NE